Efficacy and safety of flaxseed hull extract in the symptomatic management of benign prostatic hyperplasia
The study included men with an American Urological Association Symptom Index (AUASI) score of ≥ 13 and finally, 60 completers were assessed at the end of 8 weeks also for post voiding urine, prostate size, serum testosterone, and DHT. Significant improvement of obstructive symptoms and better management of irritable BPH symptoms were achieved in all groups after treatment. The sponsor of this study was Frutarom with worldwide sales of its functional ingredients. Hence, the study was completed to comply with ICH-GCP guidelines and other applicable regulations for human biomedical research to make study results globally acceptable.
